IFP Advisors
ARMP icon

IFP Advisors’s Armata Pharmaceuticals ARMP Stock Holding History

IFP Advisors’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4 Buy
+1
New +$5 ﹤0.01% 5209
2019
Q1 		$7K Hold
1,679
– – ﹤0.01% 1745
2018
Q4 		$5K Hold
1,679
– – ﹤0.01% 2814
2018
Q3 		$24K Hold
1,679
– – ﹤0.01% 2352
2018
Q2 		$27K Buy
+1,679
New +$27.3K ﹤0.01% 2283
2016
Q2 		– Sell
-168
Closed -$7K – 3830
2016
Q1 		$7K Buy
+168
New +$86.1K ﹤0.01% 1745

Other funds holding ARMP

SeaCrest Wealth Management
SeaCrest Wealth Management Purchase, New York $883M AUM 33.97% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
CNBT
Cornerstone National Bank & Trust Palatine, Illinois $309M AUM 7.69% 1-Year Est. Return
Trifecta Capital Advisors
Trifecta Capital Advisors Northbrook, Illinois $808M AUM 34.69% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

IFP Advisors's ARMP Position: Q3 2026 in Review

IFP Advisors opened a new position in Armata Pharmaceuticals (ARMP) in Q3 2026: 1 share worth $4. The stake represents ﹤0.01% of the portfolio and ranks #5209 among its holdings. This is a return to the name: IFP Advisors previously reported a position in ARMP as recently as Q1 2019.

IFP Advisors first reported a position in ARMP in Q1 2016 and has held it in 6 quarters since. The position peaked at $27K in Q2 2018. 7 funds tracked by Wall St. Rank hold ARMP as of Q3 2026.

  • IFP Advisors held 1 share of Armata Pharmaceuticals worth $4 as of Q3 2026.
  • Armata Pharmaceuticals was a new IFP Advisors position in Q3 2026.
  • Armata Pharmaceuticals made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #5209 holding.
  • IFP Advisors first reported a position in Armata Pharmaceuticals in Q1 2016 and has held it in 6 quarters since.
  • IFP Advisors's Armata Pharmaceuticals position peaked at $27K in Q2 2018.
  • 7 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.